1
|
Jiang A, Handley RR, Lehnert K, Snell RG. From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research. Int J Mol Sci 2023; 24:13021. [PMID: 37629202 PMCID: PMC10455900 DOI: 10.3390/ijms241613021] [Citation(s) in RCA: 15] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 08/15/2023] [Accepted: 08/18/2023] [Indexed: 08/27/2023] Open
Abstract
Huntington's disease (HD) is a debilitating neurodegenerative genetic disorder caused by an expanded polyglutamine-coding (CAG) trinucleotide repeat in the huntingtin (HTT) gene. HD behaves as a highly penetrant dominant disorder likely acting through a toxic gain of function by the mutant huntingtin protein. Widespread cellular degeneration of the medium spiny neurons of the caudate nucleus and putamen are responsible for the onset of symptomology that encompasses motor, cognitive, and behavioural abnormalities. Over the past 150 years of HD research since George Huntington published his description, a plethora of pathogenic mechanisms have been proposed with key themes including excitotoxicity, dopaminergic imbalance, mitochondrial dysfunction, metabolic defects, disruption of proteostasis, transcriptional dysregulation, and neuroinflammation. Despite the identification and characterisation of the causative gene and mutation and significant advances in our understanding of the cellular pathology in recent years, a disease-modifying intervention has not yet been clinically approved. This review includes an overview of Huntington's disease, from its genetic aetiology to clinical presentation and its pathogenic manifestation. An updated view of molecular mechanisms and the latest therapeutic developments will also be discussed.
Collapse
Affiliation(s)
- Andrew Jiang
- Applied Translational Genetics Group, Centre for Brain Research, School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand; (R.R.H.); (K.L.); (R.G.S.)
| | | | | | | |
Collapse
|
2
|
Monitoring of Huntington’s Disease Based on Wireless Sensing Technology. APPLIED SCIENCES-BASEL 2020. [DOI: 10.3390/app10030870] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Huntington’s disease (HD) is a rare genetic disorder that cannot be cured by current medical techniques. With the development of the disease, the life of patients will become more and more difficult. It is necessary to timely and effectively evaluate the development of the patient’s condition based on the patient’s clinical symptoms to help doctors to formulate a reasonable and effective treatment plan, alleviate the condition, and improve the quality of life, which reflects humane care. Currently, wearable devices or video surveillance are generally used to monitor the patients, and these schemes have some disadvantages. This paper presents a new method to monitor patients with HD using wireless sensing technology. Firstly, experimental data were collected by the self-developed microwave sensing platform (MSP), and then the data were preprocessed. Finally, support vector machine (SVM) and random forest (RF) algorithms were used to train the model. The MSP system continuously monitors patients in a non-contact way, which will not bring inconvenience to patients’ lives, and will not involve privacy issues. The experimental results show that the prediction accuracy of SVM can be as high as 98.0% and that of RF can be as high as 96.7%, which proves the feasibility of the technical scheme described in this paper.
Collapse
|
3
|
Kay C, Hayden MR, Leavitt BR. Epidemiology of Huntington disease. HANDBOOK OF CLINICAL NEUROLOGY 2017; 144:31-46. [DOI: 10.1016/b978-0-12-801893-4.00003-1] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
4
|
Kim HJ, Shin CW, Jeon B, Park H. Survival of Korean Huntington's Disease Patients. J Mov Disord 2016; 9:166-70. [PMID: 27667189 PMCID: PMC5035942 DOI: 10.14802/jmd.16022] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2016] [Revised: 06/13/2016] [Accepted: 08/03/2016] [Indexed: 01/20/2023] Open
Abstract
OBJECTIVE The survival of Huntington's disease (HD) patients is reported to be 15-20 years. However, most studies on the survival of HD have been conducted in patients without genetic confirmation with the possible inclusion of non-HD patients, and all studies have been conducted in Western countries. The survival of patients with HD in East Asia, where its prevalence is 10-50-fold lower compared with Western populations, has not yet been reported. METHODS Forty-seven genetically confirmed Korean HD patients from independent families were included in this retrospective medical record review study. RESULTS The mean age at onset among the 47 patients was 46.1 ± 14.0 years. At the time of data collection, 25 patients had died, and these patients had a mean age at death of 57.8 ± 13.7 years. The Kaplan-Meier estimate of the median survival from onset in the 47 patients was 14.5 years (95% confidence interval: 12.3-16.6). None of the following factors were associated with the survival time in the univariate Cox regression analysis: gender, age at onset, normal CAG repeat size, mutant CAG repeat size, and the absence or presence of non-motor symptoms at onset. CONCLUSION This is the first Asian study on survival in HD patients. Survival in Korean HD patients may be shorter than that reported for Western populations, or at least is in the lower range of expected survival. A larger longitudinal observation study is needed to confirm the results found in this study.
Collapse
Affiliation(s)
- Han-Joon Kim
- Department of Neurology, Movement Disorder Center, Parkinson Study Group, and Neuroscience Research Institute, College of Medicine, Seoul National University, Seoul, Korea
| | - Chae-Won Shin
- Department of Neurology, Movement Disorder Center, Parkinson Study Group, and Neuroscience Research Institute, College of Medicine, Seoul National University, Seoul, Korea
| | - Beomseok Jeon
- Department of Neurology, Movement Disorder Center, Parkinson Study Group, and Neuroscience Research Institute, College of Medicine, Seoul National University, Seoul, Korea
| | - Hyeyoung Park
- Department of Neurology, Movement Disorder Center, Parkinson Study Group, and Neuroscience Research Institute, College of Medicine, Seoul National University, Seoul, Korea
| |
Collapse
|
5
|
Wexler NS, Collett L, Wexler AR, Rawlins MD, Tabrizi SJ, Douglas I, Smeeth L, Evans SJ. Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review. BMJ Open 2016; 6:e009070. [PMID: 26908513 PMCID: PMC4769413 DOI: 10.1136/bmjopen-2015-009070] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2015] [Revised: 09/24/2015] [Accepted: 10/15/2015] [Indexed: 11/06/2022] Open
Abstract
OBJECTIVES The prevalence of Huntington's disease (HD) recorded in the UK primary care records has increased twofold between 1990 and 2010. This investigation was undertaken to assess whether this might be due to an increased incidence. We have also undertaken a systematic review of published estimates of the incidence of HD. SETTING Incident patients with a new diagnosis of HD were identified from the primary care records of the Clinical Practice Research Datalink (CPRD). The systematic review included all published estimates of the incidence of HD in defined populations. PARTICIPANTS A total of 393 incident cases of HD were identified from the CPRD database between 1990 and 2010 from a total population of 9,282,126 persons. PRIMARY AND SECONDARY OUTCOME MEASURES The incidence of HD per million person-years was estimated. From the systematic review, the extent of heterogeneity of published estimates of the incidence of HD was examined using the I(2) statistic. RESULTS The data showed that the incidence of HD has remained constant between 1990 and 2010 with an overall rate of 7.2 (95% CI 6.5 to 7.9) per million person-years. The systematic review identified 14 independent estimates of incidence with substantial heterogeneity and consistently lower rates reported in studies from East Asia compared with those from Australia, North America and some--though not all--those from Europe. Differences in incidence estimates did not appear to be explained solely by differences in case ascertainment or diagnostic methods. CONCLUSIONS The rise in the prevalence of diagnosed HD in the UK, between 1990 and 2010, cannot be attributed to an increase in incidence. Globally, estimates of the incidence of HD show evidence of substantial heterogeneity with consistently lower rates in East Asia and parts of Europe. Modifiers may play an important role in determining the vulnerability of different populations to expansions of the HD allele.
Collapse
Affiliation(s)
- Nancy S Wexler
- Department of Neurology and Psychiatry, Columbia University, New York, New York, USA
- Hereditary Disease Foundation, New York, New York, USA
| | - Laura Collett
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine,London, UK
| | | | - Michael D Rawlins
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine,London, UK
| | - Sarah J Tabrizi
- Department of Neurodegenerative Diseases, Institute of Neurology, University College London,London, UK
| | - Ian Douglas
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine,London, UK
| | - Liam Smeeth
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine,London, UK
| | - Stephen J Evans
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine,London, UK
| |
Collapse
|
6
|
Holm IE, Alstrup AKO, Luo Y. Genetically modified pig models for neurodegenerative disorders. J Pathol 2015; 238:267-87. [DOI: 10.1002/path.4654] [Citation(s) in RCA: 72] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2015] [Revised: 09/22/2015] [Accepted: 10/05/2015] [Indexed: 12/12/2022]
Affiliation(s)
- Ida E Holm
- Department of Pathology; Randers Hospital; 8930 Randers Denmark
- Department of Clinical Medicine; Aarhus University; 8000 Aarhus C Denmark
| | | | - Yonglun Luo
- Department of Biomedicine; Aarhus University; 8000 Aarhus C Denmark
| |
Collapse
|
7
|
Jiang H, Sun YM, Hao Y, Yan YP, Chen K, Xin SH, Tang YP, Li XH, Jun T, Chen YY, Liu ZJ, Wang CR, Li H, Pei Z, Shang HF, Zhang BR, Gu WH, Wu ZY, Tang BS, Burgunder JM. Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls. Eur J Neurol 2014; 21:637-42. [PMID: 24471773 DOI: 10.1111/ene.12366] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2013] [Accepted: 12/17/2013] [Indexed: 02/05/2023]
Affiliation(s)
- H. Jiang
- Department of Neurology; Xiangya Hospital; Central South University; Changsha China
- Key Laboratory of Hunan Province in Neurodegenerative Disorders; State Key Laboratory of Medical Genetics of China; Central South University; Changsha China
| | - Y. M. Sun
- Department of Neurology; Institute of Neurology; Huashan Hospital; Shanghai Medical College; Fudan University; Shanghai China
| | - Y. Hao
- Department of Neurology; China−Japan Friendship Hospital; Beijing China
| | - Y. P. Yan
- Department of Neurology; Second Affiliated Hospital; College of Medicine; Zhejiang University; Hangzhou China
| | - K. Chen
- Department of Neurology; West China Hospital; Sichuan University; Chengdu China
| | - S. H. Xin
- First Affiliated Hospital of Sun Yat-Sen University; Guangzhou China
| | - Y. P. Tang
- Department of Medical Genetics; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China
| | - X. H. Li
- First Affiliated Hospital of Sun Yat-Sen University; Guangzhou China
| | - T. Jun
- Department of Neurology; Second Affiliated Hospital; College of Medicine; Zhejiang University; Hangzhou China
| | - Y. Y. Chen
- Department of Neurology; China−Japan Friendship Hospital; Beijing China
| | - Z. J. Liu
- Department of Neurology; Institute of Neurology; Huashan Hospital; Shanghai Medical College; Fudan University; Shanghai China
| | - C. R. Wang
- Department of Neurology; Xiangya Hospital; Central South University; Changsha China
| | - H. Li
- Department of Medical Genetics; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China
| | - Z. Pei
- First Affiliated Hospital of Sun Yat-Sen University; Guangzhou China
| | - H. F. Shang
- Department of Neurology; West China Hospital; Sichuan University; Chengdu China
| | - B. R. Zhang
- Department of Neurology; Second Affiliated Hospital; College of Medicine; Zhejiang University; Hangzhou China
| | - W. H. Gu
- Department of Neurology; China−Japan Friendship Hospital; Beijing China
| | - Z. Y. Wu
- Department of Neurology; Institute of Neurology; Huashan Hospital; Shanghai Medical College; Fudan University; Shanghai China
| | - B. S. Tang
- Department of Neurology; Xiangya Hospital; Central South University; Changsha China
| | - J.-M. Burgunder
- Department of Neurology; Xiangya Hospital; Central South University; Changsha China
- Department of Neurology; West China Hospital; Sichuan University; Chengdu China
- First Affiliated Hospital of Sun Yat-Sen University; Guangzhou China
- Swiss Huntington's Disease Centre; Department of Neurology; University of Bern; NeuroBu Clinics; Bern Switzerland
| | | |
Collapse
|
8
|
Quarrell O, O'Donovan KL, Bandmann O, Strong M. The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis. PLOS CURRENTS 2012; 4:e4f8606b742ef3. [PMID: 22953238 PMCID: PMC3426104 DOI: 10.1371/4f8606b742ef3] [Citation(s) in RCA: 72] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Juvenile Huntington's disease (JHD) is usually defined as Huntington's disease with an onset ≤ 20 years. The proportion of JHD cases reported in studies of Huntington's disease (HD) varies. A review of the literature found 62 studies that reported the proportion of JHD cases amongst all HD cases. The proportion of JHD cases in these studies ranged from 1% to 15%, and in a meta-analysis the pooled proportion of JHD cases was 4.92% (95% confidence interval of 4.07% to 5.84%). Limiting the analysis to the 25 studies which used multiple methods of ascertainment resulted in a similar pooled proportion of 5.32%, (95% confidence interval 4.18% to 6.60%). A small difference was observed when the meta-analysis was restricted to studies from countries defined by the World Bank as high income, that used multiple methods of ascertainment, and that were conducted since 1980 (4.81%, 95% confidence interval 3.31% to 6.58%, n=11). This contrasts with the pooled result from three post 1980 studies using multiple methods of ascertainment from South Africa and Venezuela, defined by the World Bank as upper middle income, where the estimated mean proportion was 9.95%, (95% confidence interval 6.37% to 14.22%). These results, which are expected to be more robust than those from a single study alone, may be helpful in estimating the proportion of JHD cases in a given population. Key Words: Juvenile Huntington's disease, prevalence, epidemiology.
Collapse
|
9
|
Zheng Z, Burgunder JM, Shang H, Guo X. Huntington's like conditions in China, A review of published Chinese cases. PLOS CURRENTS 2012; 4:RRN1302. [PMID: 22453898 PMCID: PMC3278225 DOI: 10.1371/currents.rrn1302] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 02/09/2012] [Indexed: 02/05/2023]
Abstract
BACKGROUND Knowledge about HD in China is lacking in the international literature. We have therefore analyzed the Chinese literature to thoroughly explore the clinical characteristics of Huntington disease in China. METHODS A computer-based online search of China National Knowledge Infrastructure was performed to review case reports concerning HD published between January 1980 and April of 2011, and the clinical characteristics were extracted. RESULTS A total of 92 studies involving 279 patients (157 males and 122 females) were collected, 82.0% of which were from provinces of North China. Most of the cases (97.8%) had a family history of HD, and paternal inheritance (65.5%) was higher than maternal inheritance (34.5%). Onset age was 35.8 (± 11.8) years, death occurred with 45.6 (± 13.5) years after a course of 11.6 (± 5.6) years. Involuntary movements were the most frequent reported presentation (found in 52.3%, including 64.4% in the entire body, 19.8% in the upper limbs, and 13.7% in the head and face). Psychiatric symptoms at onset were reported in 16.1%, and cognitive impairment in 1.8%. With disease progression, 99.6% of patients had abnormal movements, 67.9% cognitive impairment, and 35.0% suffered psychiatric symptoms. Of the reported patients, only 22 underwent IT15 gene testing with positive results. CONCLUSION HD is a well-reported entity in Chinese medical literature, however, only a small number of instances have been proven by molecular diagnosis. Most of the features resemble what is known in other countries. The highly predominant motor presentation, and the higher male prevalence as well as the apparent concentration in Northern China may be due to observational bias. There is therefore a need to prospectively examine cohorts of patients with appropriate comprehensive assessment tools including genetic testing.
Collapse
Affiliation(s)
- Zhenzhen Zheng
- Department of Neurology,West China Hospital, Sichuan University, Chengdu Wai Nan Guo Xue Xiang 37# Sichuan, P.R.China and Prof. M.D. Department of Neurology, University of Bern, Switzerland and University of Sichuan, Chengdu, China
| | | | | | | |
Collapse
|
10
|
HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet 2011; 19:561-6. [PMID: 21248742 DOI: 10.1038/ejhg.2010.229] [Citation(s) in RCA: 106] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
Huntington disease (HD) results from CAG expansion in the huntingtin (HTT) gene. Although HD occurs worldwide, there are large geographic differences in its prevalence. The prevalence in populations derived from Europe is 10-100 times greater than in East Asia. The European general population chromosomes can be grouped into three major haplogroups (group of similar haplotypes): A, B and C. The majority of HD chromosomes in Europe are found on haplogroup A. However, in the East-Asian populations of China and Japan, we find the majority of HD chromosomes are associated with haplogroup C. The highest risk HD haplotypes (A1 and A2), are absent from the general and HD populations of China and Japan, and therefore provide an explanation for why HD prevalence is low in East Asia. Interestingly, both East-Asian and European populations share a similar low level of HD on haplogroup C. Our data are consistent with the hypothesis that different HTT haplotypes have different mutation rates, and geographic differences in HTT haplotypes explain the difference in HD prevalence. Further, the bias for expansion on haplogroup C in the East-Asian population cannot be explained by a higher average CAG size, as haplogroup C has a lower average CAG size in the general East-Asian population compared with other haplogroups. This finding suggests that CAG-tract size is not the only factor important for CAG instability. Instead, the expansion bias may be because of genetic cis-elements within the haplotype that influence CAG instability in HTT, possibly through different mutational mechanisms for the different haplogroups.
Collapse
|
11
|
Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, Collins JA, Semaka A, Hudson TJ, Hayden MR. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009; 84:351-66. [PMID: 19249009 DOI: 10.1016/j.ajhg.2009.02.003] [Citation(s) in RCA: 153] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2008] [Revised: 01/13/2009] [Accepted: 02/03/2009] [Indexed: 12/19/2022] Open
Abstract
Huntington disease (HD) is an autosomal-dominant disorder that results from >or=36 CAG repeats in the HD gene (HTT). Approximately 10% of patients inherit a chromosome that underwent CAG expansion from an unaffected parent with <36 CAG repeats. This study is a comprehensive analysis of genetic diversity in HTT and reveals that HD patients of European origin (n = 65) have a significant enrichment (95%) of a specific set of 22 tagging single nucleotide polymorphisms (SNPs) that constitute a single haplogroup. The disease association of many SNPs is much stronger than any previously reported polymorphism and was confirmed in a replication cohort (n = 203). Importantly, the same haplogroup is also significantly enriched (83%) in individuals with 27-35 CAG repeats (intermediate alleles, n = 66), who are unaffected by the disease, but have increased CAG tract sizes relative to the general population (n = 116). These data support a stepwise model for CAG expansion into the affected range (>or=36 CAG) and identifies specific haplogroup variants in the general population associated with this instability. The specific variants at risk for CAG expansion are not present in the general population in China, Japan, and Nigeria where the prevalence of HD is much lower. The current data argue that cis-elements have a major predisposing influence on CAG instability in HTT. The strong association between specific SNP alleles and CAG expansion also provides an opportunity of personalized therapeutics in HD where the clinical development of only a small number of allele-specific targets may be sufficient to treat up to 88% of the HD patient population.
Collapse
|
12
|
Aubeeluck A, Wilson E. Huntington's disease. Part 1: essential background and management. ACTA ACUST UNITED AC 2008; 17:146-51. [PMID: 18414253 DOI: 10.12968/bjon.2008.17.3.28402] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Huntington's disease is a neurodegenerative disorder that manifests in motor, cognitive and behavioural symptoms, gradually progressing over a number of years, if not decades. The complexity and unpredictability of the disease poses challenges for health-and social-care professionals. This article provides an essential background to the understanding and management of care for people with Huntington's disease, presenting a discussion of the main stages to highlight the symptoms and challenges associated with the disease. The article then moves on to discuss potential management and therapy issues identifying some key considerations in the treatment of the disease. Finally, the combined role of the multidisciplinary team is highlighted in providing health and social care to people with Huntington's disease as it progresses and increasing professional support is required.
Collapse
Affiliation(s)
- Aimee Aubeeluck
- School of Nursing, Queen's Medical Centre, University of Nottingham, UK
| | | |
Collapse
|
13
|
Wang CK, Wu YR, Hwu WL, Chen CM, Ro LS, Chen ST, Gwinn-Hardy K, Yang CC, Wu RM, Chen TF, Wang HC, Chao MC, Chiu MJ, Lu CJ, Lee-Chen GJ. DNA haplotype analysis of CAG repeat in Taiwanese Huntington's disease patients. Eur Neurol 2004; 52:96-100. [PMID: 15273431 DOI: 10.1159/000079938] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2003] [Accepted: 05/25/2004] [Indexed: 11/19/2022]
Abstract
We studied the expanded CAG repeat and adjacent CCG repeat in 53 Huntington's disease (HD) patients and 172 unrelated normal subjects matched to the patients for ethnic origin. The range of the CAG repeat varied from 38 to 109 in the HD patients and from 10 to 29 in the control group. A significant negative correlation was found between the age at onset and the CAG expansion, with no significant influence of the adjacent CCG repeat on the age at onset by multiple regression analysis. Allelic association using CCG repeat and 2 flanking dinucleotide repeat markers within 150 kb of the HD gene revealed linkage disequilibrium for 2 of 3 markers. Haplotype analysis of 24 HD families using these markers identified 3 major haplotypes underlying 87.5% of HD chromosomes. The data suggested frequent haplotypes in the Taiwanese population on which one or more mutational events leading to the disease occurred.
Collapse
Affiliation(s)
- C K Wang
- Department of Life Science, National Taiwan Normal University, Taipei, Taiwan, ROC
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Saleem Q, Roy S, Murgood U, Saxena R, Verma IC, Anand A, Muthane U, Jain S, Brahmachari SK. Molecular analysis of Huntington's disease and linked polymorphisms in the Indian population. Acta Neurol Scand 2003; 108:281-6. [PMID: 12956863 DOI: 10.1034/j.1600-0404.2003.00133.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVES To understand the population variation and haplotypes of Huntington's disease (HD) in India we have analysed CAG repeats at the HD locus together with closely linked polymorphisms in both HD patients and normal controls. MATERIALS AND METHODS The CAG repeat and linked polymorphisms were analysed in 30 Indian HD families together with 250 ethnically matched controls using fluorescent polymerase chain reaction (PCR) based size estimation. RESULTS CAG repeats at the HD locus in the normal population showed a mean size of 17.99 +/- 2.66 repeats (range nine to 33 repeats). The HD mutation in our families did not show any significant association with either the (CCG)7 or (CCG)10 allele while haplotype analysis suggested the over-representation of the 7-2-I (CCG-D4s127-Delta 2642 loci) haplotype in a subset of families. CONCLUSION The distribution of CAG repeats in the normal population suggests a higher prevalence of HD, closer to that seen in Western Europe. Haplotype analysis suggests the presence of a founder mutation in a subset of families and provides evidence for multiple and geographically distinct origins for the HD mutation in India.
Collapse
Affiliation(s)
- Q Saleem
- Functional Genomics Unit, Centre for Biochemical Technology (CSIR), Mall Road, Delhi, India
| | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Abstract
OBJECTIVE To review the psychosocial aspects of Chinese families with Huntington's disease (HD) in Hong Kong. METHOD The psychosocial aspects of five Chinese families in Hong Kong were studied with in-depth interviews and detailed analysis of case records. RESULTS Patients with HD are found to suffer from certain specific psychosocial adversities, including marital disharmony, social stigma and increased suicidal risk in those with relatively well-preserved cognitive function. A low request rate for presymptomatic testing for HD is also observed among these cases. CONCLUSIONS Though the genetic defect in HD is universal and cuts across cultures, the problems faced by these patients and their families are never the same. Despite limited local experience due to a much lower prevalence, Chinese HD patients in Hong Kong are found to have specific needs that emerge from their ethno-historical background.
Collapse
Affiliation(s)
- Tak Yu Leung
- The Chinese University of Hong Kong, Prince of Wales Hospital, China
| | | |
Collapse
|
16
|
Al-Jader LN, Newcombe RG, Hayes S, Murray A, Layzell J, Harper PS. Developing a quality scoring system for epidemiological surveys of genetic disorders. Clin Genet 2002; 62:230-4. [PMID: 12220439 DOI: 10.1034/j.1399-0004.2002.620308.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
A prototype database of published articles containing data on the frequency of human inherited disorders has been developed for use in clinical contexts, in medical research, for epidemiological studies, and in the planning of genetic services. It can be accessed at http://www.uwcm.ac.uk/uwcm/mg/fidd/. The information available in the literature comes from a wide range of publications, not all can be described primarily as epidemiological surveys. A preliminary assessment indicated that the quality of published articles was highly variable. Very few published articles describe quality-scoring systems for epidemiological surveys in general. We have developed a new scoring system to assess the quality of published articles on genetic disease frequency based on five main criteria and nine component scores. We carried out a first pilot study, to test its feasibility, usefulness and reproducibility. Eleven assessors scored six papers on the epidemiology of Huntington disease. As a result of these findings, we modified the scoring system to define each component more clearly. This was then evaluated in a second pilot study, which utilized six assessors to score 20 papers. The consensus between assessors remained relatively poor. We feel that while it may be possible to improve the scoring system further, the degree of improvement attainable may be limited by the poor standards of content and presentation of published surveys, which led to confusion and uncertainty by assessors. This pilot exercise has shown the need to raise the awareness of researchers and clinicians about the basic quality standards to be required of epidemiological genetic surveys.
Collapse
Affiliation(s)
- L N Al-Jader
- Department of Public Health, Iechyd Morgannwg Health, Gwent, Wales.
| | | | | | | | | | | |
Collapse
|
17
|
Abstract
Degenerative diseases of the central nervous system are significant causes of mortality among elderly people in industrialized countries. For the most part, the causes of these diseases are unknown. It is also very difficult to diagnose this type of disease quickly and accurately. This article reviews the epidemiological research on the principal neurodegenerative disorders, focusing on geographical, hereditary and viral and toxicological exposure correlates. We look in particular at the effect of exposure to toxins as well as the effect that deficiencies of elements such as calcium and selenium could have on the development of these neurological diseases. We also consider the possible protectionist effect of some variables on the development of certain neurological diseases.
Collapse
Affiliation(s)
- J F Emard
- Projet IMAGE, Centre Hospitalier Côte-des-Neiges, Montréal, Québec, Canada
| | | | | |
Collapse
|
18
|
Wong MT, Chang PC, Yu YL, Chan YW, Chan V. Psychosocial impact of Huntington's disease on Hong Kong Chinese families. Acta Psychiatr Scand 1994; 90:16-8. [PMID: 7976443 DOI: 10.1111/j.1600-0447.1994.tb01549.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Twenty-eight asymptomatic relatives from 7 Chinese families with Huntington's disease (HD) received psychosocial assessment. One third of these subjects (n = 9) had symptoms of anxiety and depression that warranted a Present State Examination (PSE) diagnosis. One quarter of these subjects (n = 8) would contemplate suicide if their predictive testing indicated a high risk of having the disease. This suicidal risk was associated with a PSE diagnosis of depression and a stress-coping repertoire with a high proportion of coping strategies of the avoidance type at the time of interview. Early and close liaison with these subjects for the detection of mental symptoms and provision of counselling on a balanced and positive coping style is essential.
Collapse
Affiliation(s)
- M T Wong
- Department of Psychiatry, University of Hong Kong
| | | | | | | | | |
Collapse
|